We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
(+10%)
Cap. Flow
+$4.07B
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$754M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$743M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$526M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$384M |
| 5 |
British American Tobacco
BTI
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$308M |
| 2 |
AGN
Allergan plc
AGN
|
+$233M |
| 3 |
BATS
Bats Global Markets, Inc.
BATS
|
+$190M |
| 4 |
ACAS
American Capital Ltd
ACAS
|
+$186M |
| 5 |
SLB Ltd
SLB
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.15% |
| 2 | Technology | 9.78% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 6.76% |
| 5 | Consumer Staples | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGYP
1851
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $3.4M | ﹤0.01% |
728,352
+487,434
| +202% | +$2.83M |
|
1852
Abercrombie & Fitch
ANF
$4.46B
| $3.39M | ﹤0.01% |
284,205
-89,037
| -24% | -$1.06M |
|
1853
Essent Group
ESNT
$6.08B
| $3.39M | ﹤0.01% |
93,657
-8,280
| -8% | -$287K |
|
1854
Halozyme
HALO
$9.79B
| $3.39M | ﹤0.01% |
261,374
+128,861
| +97% | +$1.63M |
|
|
PKY
1855
DELISTED
Parkway, Inc.
PKY
| $3.39M | ﹤0.01% |
170,230
-131
| -0.1% | -$2.74K |
|
1856
CALL
National Beverage
FIZZ
$2.97B
| $3.38M | ﹤0.01% |
+80,000
| New | +$2.41M |
|
1857
U-Haul Holding Co
UHAL
$13.8B
| $3.38M | ﹤0.01% |
88,690
+10
| +0% | +$376 |
|
|
MDR
1858
CALL
DELISTED
McDermott International
MDR
| $3.38M | ﹤0.01% |
166,667
+135,067
| +427% | +$2.98M |
|
1859
BJ's Restaurants
BJRI
$1.45B
| $3.37M | ﹤0.01% |
83,501
+54,981
| +193% | +$2.03M |
|
1860
CALL
CNX Resources
CNX
$4.97B
| $3.37M | ﹤0.01% |
+240,720
| New | +$3.39M |
|
1861
Liberty Latin America Class C
LILAK
$1.63B
| $3.36M | ﹤0.01% |
170,381
-46,641
| -21% | -$918K |
|
|
GBT
1862
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.36M | ﹤0.01% |
91,115
-2,461
| -3% | -$62K |
|
1863
Louisiana-Pacific
LPX
$5.06B
| $3.35M | ﹤0.01% |
135,076
-70,609
| -34% | -$1.56M |
|
|
HT
1864
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $3.35M | ﹤0.01% |
178,373
-5,888
| -3% | -$118K |
|
|
BCIC
1865
BCP Investment Corp
BCIC
$87.9M
| $3.35M | ﹤0.01% |
+82,350
| New | +$3.3M |
|
|
CEO
1866
DELISTED
CNOOC Limited
CEO
| $3.35M | ﹤0.01% |
27,935
-1,360
| -5% | -$166K |
|
1867
SiteOne Landscape Supply
SITE
$4.16B
| $3.35M | ﹤0.01% |
69,097
-604
| -0.9% | -$24.1K |
|
|
FIBG
1868
DELISTED
CS FI Enhanced Big Cap Growth ETN
FIBG
| $3.33M | ﹤0.01% |
46,744
+660
| +1% | +$45.4K |
|
1869
WaFd
WAFD
$2.7B
| $3.33M | ﹤0.01% |
100,529
-26,987
| -21% | -$904K |
|
|
ACOR
1870
DELISTED
Acorda Therapeutics
ACOR
| $3.32M | ﹤0.01% |
1,319
+154
| +13% | +$443K |
|
|
TPCO
1871
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $3.31M | ﹤0.01% |
238,156
-34,276
| -13% | -$470K |
|
|
KYNB
1872
Kyntra Bio
KYNB
$27.6M
| $3.31M | ﹤0.01% |
5,368
+3,406
| +174% | +$2.07M |
|
|
ISBC
1873
DELISTED
Investors Bancorp, Inc.
ISBC
| $3.31M | ﹤0.01% |
229,908
-52,572
| -19% | -$753K |
|
|
SPTN
1874
DELISTED
SpartanNash
SPTN
| $3.3M | ﹤0.01% |
94,298
-2,020
| -2% | -$74K |
|
|
ENLK
1875
DELISTED
EnLink Midstream Partners, LP
ENLK
| $3.3M | ﹤0.01% |
180,211
+47,136
| +35% | +$867K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2017 Portfolio in Review
As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.
- Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
- Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
- Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
- Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
- Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
- Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
- Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.
Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.